- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Eribulin – November 2016
Eribulin: Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL; Halaven®
Last updated
3 March 2017